skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,287  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
COVID-19: Drug Targets and Potential Treatments
Material Type:
Article
Add to My Research

COVID-19: Drug Targets and Potential Treatments

Journal of Medicinal Chemistry, 2020-11 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.acs.org/content/acs/en/terms.html ;DOI: 10.1021/acs.jmedchem.0c00606

Digital Resources/Online E-Resources

2
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
Material Type:
Article
Add to My Research

Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing

Clinical infectious diseases, 2020-12, Vol.71 (9), p.2459-2468 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa530 ;PMID: 32358954

Full text available

3
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
Material Type:
Article
Add to My Research

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

New England Journal of Medicine, 2022-04, Vol.386 (16), p.1579-1580 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2201849 ;PMID: 35294809

Digital Resources/Online E-Resources

4
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
Material Type:
Article
Add to My Research

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

Nature (London), 2023-01, Vol.613 (7944), p.558-564 [Peer Reviewed Journal]

2022. The Author(s). ;Copyright Nature Publishing Group Jan 19, 2023 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-05514-2 ;PMID: 36351451

Full text available

5
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Material Type:
Article
Add to My Research

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

Cell, 2022-02, Vol.185 (3), p.447-456.e11 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.12.032 ;PMID: 35026151

Full text available

6
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Material Type:
Article
Add to My Research

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

BMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964

Full text available

7
A tale of two antiviral targets - and the COVID-19 drugs that bind them
Material Type:
Article
Add to My Research

A tale of two antiviral targets - and the COVID-19 drugs that bind them

Nature reviews. Drug discovery, 2022-01, Vol.21 (1), p.3-5 [Peer Reviewed Journal]

Nature 2022. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-021-00202-8 ;PMID: 34857884

Full text available

8
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
Material Type:
Article
Add to My Research

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

New England Journal of Medicine, 2022-08, Vol.387 (5), p.468-470 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2207519 ;PMID: 35857646

Digital Resources/Online E-Resources

9
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
Material Type:
Article
Add to My Research

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

New England Journal of Medicine, 2022-04, Vol.386 (15), p.1475-1477 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2201933 ;PMID: 35263535

Digital Resources/Online E-Resources

10
Drug repurposing approach to fight COVID-19
Material Type:
Article
Add to My Research

Drug repurposing approach to fight COVID-19

Pharmacological reports, 2020-12, Vol.72 (6), p.1479-1508 [Peer Reviewed Journal]

Maj Institute of Pharmacology Polish Academy of Sciences 2020 ;ISSN: 1734-1140 ;EISSN: 2299-5684 ;DOI: 10.1007/s43440-020-00155-6 ;PMID: 32889701

Full text available

11
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
Material Type:
Article
Add to My Research

Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors

Nature communications, 2021-02, Vol.12 (1), p.743-9, Article 743 [Peer Reviewed Journal]

This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-21060-3 ;PMID: 33531496

Full text available

12
Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities
Material Type:
Article
Add to My Research

Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities

Journal of Medicinal Chemistry, 2020-11 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.acs.org/content/acs/en/terms.html ;DOI: 10.1021/acs.jmedchem.0c00502

Digital Resources/Online E-Resources

13
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Material Type:
Article
Add to My Research

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

New England Journal of Medicine, 2022-01, Vol.386 (4), p.305-315 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116846 ;PMID: 34937145

Digital Resources/Online E-Resources

14
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Material Type:
Article
Add to My Research

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Nature (London), 2022-03, Vol.603 (7902), p.706-714 [Peer Reviewed Journal]

2022. The Author(s). ;Copyright Nature Publishing Group Mar 24, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04474-x ;PMID: 35104837

Full text available

15
Role of favipiravir in the treatment of COVID-19
Material Type:
Article
Add to My Research

Role of favipiravir in the treatment of COVID-19

International journal of infectious diseases, 2021-01, Vol.102, p.501-508 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved. ;2020 The Authors 2020 ;ISSN: 1201-9712 ;EISSN: 1878-3511 ;DOI: 10.1016/j.ijid.2020.10.069 ;PMID: 33130203

Full text available

16
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Material Type:
Article
Add to My Research

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

The Lancet, 2020-12, Vol.396 (10267), p.1979-1993 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by-nc-nd/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32466-1 ;PMID: 33220855

Digital Resources/Online E-Resources

17
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
Material Type:
Article
Add to My Research

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

New England Journal of Medicine, 2022-03, Vol.386 (10), p.995-998 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119407 ;PMID: 35081300

Digital Resources/Online E-Resources

18
A critical overview of computational approaches employed for COVID-19 drug discovery
Material Type:
Article
Add to My Research

A critical overview of computational approaches employed for COVID-19 drug discovery

Chemical Society Reviews, 2021-08, Vol.50 (16), p.9121-9151 [Peer Reviewed Journal]

2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://pubs.rsc.org/en/Journals/ArticleCollectionLanding?themeId=1eac56a1-4121-43c5-b3ec-3d6f9d9226fb&journalName. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0306-0012 ;EISSN: 1460-4744 ;DOI: 10.1039/D0CS01065K

Digital Resources/Online E-Resources

19
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis
Material Type:
Article
Add to My Research

Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis

Chest, 2021-03, Vol.159 (3), p.1019-1040 [Peer Reviewed Journal]

Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. ;2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. 2020 American College of Chest Physicians ;ISSN: 0012-3692 ;EISSN: 1931-3543 ;DOI: 10.1016/j.chest.2020.10.054 ;PMID: 33129791

Full text available

20
SARS-CoV-2 Variants in Patients with Immunosuppression
Material Type:
Article
Add to My Research

SARS-CoV-2 Variants in Patients with Immunosuppression

New England Journal of Medicine, 2021-08, Vol.385 (6), p.562-566 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMsb2104756 ;PMID: 34347959

Digital Resources/Online E-Resources

Results 1 - 20 of 1,287  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,274)

Refine My Results

Creation Date 

From To
  1. Before 2020  (1)
  2. 2020 To 2020  (217)
  3. 2021 To 2021  (758)
  4. 2022 To 2023  (269)
  5. After 2023  (43)
  6. More options open sub menu

Language 

  1. English  (1,286)
  2. Japanese  (207)
  3. Norwegian  (3)
  4. Chinese  (1)
  5. French  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait